Esperanza Munoz Muela

I am working on HIV field. Aiming at improving patients’ life, we are looking for keys in the immunologic discordant response. We are also carrying out some clinical trials which objective is to reduce ART from three drugs to only two. We assess HIV-reservoir by ddPCR, as well as immunologic and inflammatory states by multicolor flow cytometry along with ELISA. Recently, we have started to broad our horizons studying immunometabolism, mainly by Seahorse analyzer, and looking into monocytes.